Sea Pharmaceuticals

About:

Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.

Website: https://www.seapharmaceuticals.com

Description:

Sea Pharmaceuticals is a neurotherapeutics company specializing in the development of new oral molecules for the treatment of tinnitus and epilepsy. The company invents, discovers, and advances research & development (R&D), and plans to commercialize Sea's own novel proprietary synthetic small molecules as innovative treatments for Tinnitus, Epilepsy, and other high medical need therapeutic neurology indications including genetic disorders of the CNS.

Total Funding Amount:

$1.69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-03-01

Founders:

James Pearson

Number of Employees:

11-50

Last Funding Date:

2021-01-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai